Okayama M, Kitabatake S, Sato M, Fujimori, Daiju Ichikawa, Matsushita M, Suto Y, Iwasaki G, Yamada T, Kiuchi F, Hirao M, Kunieda H, Osada M, Okamoto S, Hattori Y. A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress. Biochemical and Biophysical Research Communications 2018;505:787-793
Sakurai M, Toyama T, Kikuchi T, Kato J, Shimizu T, Koda Y, Karigane D, Yamane Y, Abe R, Yamazaki R, Nakazato T, Nakahara T, Jinzaki M, Okamoto S, Mori T. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma. . Int J Hematol. 2018;107:194-200
Okamoto S, Teshima T, Kosugi-Kanaya M, Kahata K, Kawashima N, Kato J, Mori T, Ozawa Y, Miyamura K. Extracorporeal photoperesis with TC-V in Japanese patients with steroid-resistanat chronic graft-versus-host disease. Int J Hematol. 2018;108:298-305
Takanashi S, Nakazato T, Aisa Y, Ito C, Arakaki H, Osada Y, Hirano M, Mori T. The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders. Ann Hematol 2018;doi: 10.1007/s00277-018-3327-4.
Saito S, Suzuki K, Yoshimoto K, Kaneko Y, Yamaoka K, Shimizu T, Mori T, Okamoto S, Kameyama K, Amano K, Tamaru JI, Tokuhira M, Takeuchi T. Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment.. Front Immunol. 2018;9:621
Konuma T, Kondo T, Kawata T, Iwato K, Sato Y, Mori T, Ohashi K, Nakazawa H, Sugahara H, Ago H, Eto T, Imamura Y, Fukuda T, Kanda Y, Atsuta Y, Yano S. Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Hematopoietic cell transplantation for acute panmyelosis with myelofibrosis: a retrospective study in Japan. Biol Blood Marrow Transplant. 2018 Aug 10. pii: S1083-8791(18)30460-9.
Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R. Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study. Transfus Med Rev. 2018;Jun 1. pii: S0887-7963(18)30023-3.
Fujita Y, Nakazato T, Ito C, Masuda K, Osada Y, Aisa Y, Mori T. A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment. Ann Hematol. 2018 Oct;97(10):2009-2010.
Yoshinaga N, Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Ichinohe T, Atsuta Y, Takaori-Kondo A. Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. Biol Blood Marrow Transplant. 2018 Mar 15. pii: S1083-8791(18)30122-8.
Yamazaki R, Kikuchi T, Kato J, Sakurai M, Koda Y, Hashida R, Yamane Y, Abe R, Hasegawa N, Okamoto S, Mori T. Recurrent bacterial pneumonia due to immunoglobulin G2 subclass deficiency after allogeneic hematopoietic stem cell transplantation: Efficacy of immunoglobulin replacement. Transpl Infect Dis. 2018 Jun;20(3):e12863. doi: 10.1111/tid.12863.
Kawamura K, Nakasone H, Kurosawa S, Yoshimura K, Misaki Y, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Kusuda M, Kameda K, Wada H, Ishihara Y, Sato M, Terasako-Saito K, Kikuchi M, Kimura SI, Tanihara A, Kako S, Kanamori H, Mori T, Takahashi S, Taniguchi S, Atsuta Y, Kanda Y. Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success. Biol Blood Marrow Transplant. 2018 Jul;24(7):1521-1526.
Nakazato T, Takanashi S, Hirano M, Ito C, Fujita Y, Osada Y, Aisa Y, Mori T. Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma. Ann Hematol. 2018 Aug;97(8):1489-1491.
Ogata M, Takano K, Moriuchi Y, Kondo T, Ueki T, Nakano N, Mori T, Uoshima N, Nagafuji K, Yamasaki S, Shibasaki Y, Sakai R, Kato K, Choi I, Jo Y, Eto T, Kako S, Oshima K, Fukuda T. Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group. Biol Blood Marrow Transplant. 2018 Jun;24(6):1264-1273.
Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, Hirokawa M, Atsuta Y, Nakaseko C. Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan. Biol Blood Marrow Transplant. 2018 Jun;24(6):1180-1186.
症例報告(英語)
Sakurai M, Watanuki S, Kato J, Hashida R, Yamane Y, Karigane D, Mitsuhashi T, Murata M, Ueno H, Nakazato T, Okamoto S, Mori T. Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission. Intern Med. 2018;(57):3299-3302
Sakurai M, Kato J, Toyama T, Hashida R, Yamane Y, Abe R, Koda Y, Kohashi S, Kikuchi T, Hayashi Y, Nukaga S, Ueda S, Fukunaga K, Okamoto S, Mori T. Successful Steroid Therapy for Lipoid Pneumonia Developing After Allogeneic Hematopoietic Stem Cell Transplant: A Case Report. Transplant Proc 2018;(50):4096-4098
Kikuchi T, Arai M, Koda Y, Kato J, Shimizu T, Katano H, Fujii-Nishimura Y, Sakamoto M, Ebinuma H, Nakamoto N, Kanai T, Okamoto S, Mori T. Late-onset visceral varicella-zoster virus infection presented as acute liver failure after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2019 Aug;21(4):.e13121
Matsusaka Y, Kikuchi T, Nakahara T, Iwabuchi Y, Jinzaki M. IgG4-related periarteritis of the carotid artery. QJM doi: 10.1093/qjmed/hcz068.
Karigane D, Kikuchi T, Sakurai M, Kato J, Yamane Y, Hashida R, Abe R, Hatano M, Hasegawa N, Wakayama M, Shibuya K, Okamoto S, Mori T. Invasive hepatic mucormycosis: A case report and review of the literature. J Infect Chemother. 2018;25(1):50-53. doi: 10.1016/j.jiac.2018.06.013.
Mori T, Kato J, Sakurai M, Okamoto S. Results of phase 1 study of myeloablative conditioning combined with plerixafor in high-risk leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. International Congress of BMT 2018年 Busan Poster
Shinichiro Okamoto. Importance of transplant outcome registry - JHSCT/APBMT perspectives. 5th Vietnamese-French Open Blood and Marrow Transplantaion Congress 2018年 Danang city Oral
Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Hino M, Teshima1 T, Taniguchi S, Yamashita T, InamotoY, Kanda Y, Okamoto S, Atsuta Y. Impact of past and present chronic graft-versus-host disease on quality of life in hematopoietic cell transplantation survivors. International Society for Quality of Life Research 25th Annual Conference 2018年 Dubulin Poster
Fujita H, Sasaki T, Miyamoto T, Mori T, Nakabayashi K, Hata K, Matsuura S, Matsubara Y, Amagai M, Kubo A,. Identification and molecular characterization of a CDC20 mutation in a novel mosaic variegated aneuploidy syndrome with premature aging phenotypes. International Investigative Dermatology 2018年 Orland Oral&Poster
Shinichiro Okamoto. Clinical experiences from around the world -Japan. The 1st Annual Meeting of the International Academy for Clinical Hematology 2018年 Paris Oral
Shinichiro Okamoto. Viral associated hematological diseases in Japan. The 1st Annual Meeting of the International Academy for Clinical Hematology 2018年 Paris Oral
Koichi Murakami, Daisuke Kurotaki, Wataru Kawase, Shunsuke Soma, Yumi Fukuchi, Hiroyoshi Kunimoto, Ryusuke Yoshimi, Shuhei Koide, Motohiko Oshima, Mayumi Oda, Minoru Ko, Takako Hishiki, Noriyo Hayakawa, Tomomi Matsuura, Kiichi Yanagisawa, Hiroshi Kobayashi, Miho Haraguchi, Yoshitoshi Atobe, Kengo Funakoshi, Atsushi Iwama, Keiyo Takubo, Shinichiro Okamoto, Tomohiko Tamura, Hideaki Nakajima. Regulation of mitophagy by O-linked N-acetylglucosamine transferase is essential for hematopoietic stem cell maintenance. 60th American Society of Hematology Annual Meeting 2018年 San Diego Oral
Takahiro Kamiya, Kota Mizuno, Shinji Ogura, Chisako Ito, Yuriko Fujita, Yoshinobu Aisa and Tomonori Nakazato. A Prospective Observational Study Evaluating Sarcopenia By Using the Bioelectrical Impedance Analysis in Elderly Patients with Hematologic Malignancies. 60th American Society of Hematology Annual Meeting 2018年 San Diego Poster
Shimomura Y, Hara M, Tachibana T, Ohashi K, Ozawa Y, Eto T, Uchida N, Mori T, Kanda J, Ichinohe T, Atsuta Y, Ishikawa T, Ishiyama K. Epidemiology of second allogeneic hematopoietic stem cell transplantation for patients with relapsed myelodysplastic syndrome. 60th American Society of Hematology Annual Meeting 2018年 San Diego Poster
Shimomura Y, Hara M, Konuma T, Itonaga H, Ohashi K, Ozawa Y, Eto T, Uchida N, Mori T, Tanaka J, Fukuda T, Atsuta Y, Ishikawa T, Ishiyama K. Allogeneic hematopoietic stem cell transplantation for the treatment of myelodysplastic syndrome in adolescent and young adult patients. 60th American Society of Hematology Annual Meeting 2018年 San Diego Poster
Kako S, Kanda Y, Onizuka M, Aotsuka N, Usuki K, Tachibana T, Kobayashi T, Kato J, Yano S, Shimizu H, Shono K, Tanaka M, Tsukamoto S, Mori T, Yamazaki E, Okamoto S. Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: Ksgct Prospective Study. 60th American Society of Hematology Annual Meeting 2018年 San Diego Poster
Kako S, Yamazaki H, Ohashi K, Ozawa Y, Ota S, Kanda Y, Maeda T, Kato J, Ishiyama K, Matsuoka I, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Mori T. Mixed chimerism and secondary engraftment failure in allogeneic transplantation for aplastic anemia. 60th American Society of Hematology Annual Meeting 2018年 San Diego Poster
Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, MD, Mori T, Kanda Y, Kondo T, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R. Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation. 60th American Society of Hematology Annual Meeting 2018年 San Diego Oral
Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara S, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, MD, Takahashi T,Nagai K, Minakawa K, Tanosaki R. A prospective, multicenter surveillance study for adverse events associated with hematopoietic stem cell infusion: analysis of pediatric and low body-weight recipients. 60th American Society of Hematology Annual Meeting 2018年 San Diego Poster
Mizuno S, Kawamura K, Hanamura I, Sunami K, Mori K, Nakamura F, Iida S, Nakazawa H, Makita M,Kako S, Sawa M, Ueda Y, Takahashi H, Kanda Y, Ichinohe T, Atsuta Y, Takamatsu H, Takami. A efficacy and safety of autologous stem cell transplantation in elderly patients with multiple myeloma in the era of novel agents. 60th American Society of Hematology Annual Meeting 2018年 San Diego Poster
Kasahara H, Karigane D,Yamazaki R, Fujita S, Shirosita K, Sakurai M, Koda Y, Kikuchi T, Kato J, Shimizu T, Mori T, Yatabe Y, Arai T, Murata M, Kobayashi H, Takubo K, Okamoto S. Evaluation and significance of CD25 expression in hematopoietic stem/progenitor cell fraction of bone marrow cells in chronic myelogenous leukemia patients.. 60th American Society of Hematology Annual Meeting 2018年 San Diego Poster
Shinichiro Okamoto. How the APBMT is facing the challenge. Annual Congress of Asia Pacific Blood and Marrow Transplantation 2018年 Taiwan Oral
Hitomi Nakayama, Rie Yamazaki, Jun Kato, Yuya Koda, Masatoshi Sakurai, Ryohei Abe, Chieko Sumiya, Kohei Shiroshita, Shinichiro Okamoto, Takehiko Mori. Establishment of novel monitoring assay, digital PCR, for HHV-6 reactivation after allogeneic stem cell transplantation. Annual Congress of Asia Pacific Blood and Marrow Transplantation 2018年 Taiwan Poster
Kohei Shiroshita, Koichi Murakami, Jun Kato, Masatoshi Sakurai, Yuya Koda, Rie Yamazaki, Hitomi Nakayama, Shinichiro Okamoto, Takehiko Mori. Retrospective analysis of human herpes virus-6 (HHV-6) myelitis cases after allogeneic hematopoietic stem cell transplantation. Annual Congress of Asia Pacific Blood and Marrow Transplantation 2018年 Taiwan Poster
Kato J, Shirosita K, Sumiya C, Abe R, Sakurai M, Koda Y, Kikuchi T, Shimizu T, Mori T, Okamoto S. Plerixafor for mobilization of hematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma and multiple myeloma. Annual Congress of Asia Pacific Blood and Marrow Transplantation 2018年 Taiwan Poster
Yamazaki R, Kato J, Kikuchi T, Koda Y, Sakurai M, Abe R, Nakayama H, Shiroshita K, Watanuk S, Okamoto S, Mori T. Effect of Immunoglobulin G2 subclass level on late-onset bacterial infection after allogeneic hematopoietic stem cell transplantation. Annual Congress of Asia Pacific Blood and Marrow Transplantation 2018年 Taiwan Poster
Hitomi Nakayama, Rie Yamazaki, Jun Kato, Yuya Koda, Masatoshi Sakurai, Ryohei Abe, Chieko Sumiya, Kohei Shiroshita, Shinichiro Okamoto, Takehiko Mori. HHV-6 reactivation evaluated by digital polymerase chain reaction and its association with dynamics of CD134-positive T cells after allogeneic stem cell transplantation. 45th Annual Meeting of the European Society for Bone and Marrow Transplantation. 2019年 Frankfurt Poster
Kohei Shiroshita, Koichi Murakami, Jun Kato, Masatoshi Sakurai, Yuya Koda, Rie Yamazaki, Hitomi Nakayama, Shinichiro Okamoto, Takehiko Mori. Retrospective analysis of human herpes virus-6 (HHV-6) myelitis cases after allogeneic hematopoietic stem cell transplantation.. 45th Annual Meeting of the European Society for Bone and Marrow Transplantation. 2019年 Frankfurt Poster
城下郊平、加藤淳、橋田里妙、山根裕介、甲田祐也、安部涼平、佐藤雄紀、菊池拓、清水隆之、森毅彦、岡本真一郎. Two AYA cases of methotrexate-induced leukoencephalopathy during the intensified regimen for ALL. 第80回日本血液学会学術集会 2018年 大阪 ポスター
Fujimoto A, Hiramoto H, Yamazaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R.. Risk factors and predictive scoring system for PTLD after HSCT.. 第41回日本造血細胞移植学会総会 2019年 大阪 口演
Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, Mori T, Sawa M, Ichinohe T, Atsuta Y, Kanda Y.. Impact of HLA disparity in uPBSCT in Japan. 第41回日本造血細胞移植学会総会 2019年 大阪 口演
Sakurai M, Mori T, Karigane D, Tozawa K, Matsuki E, Shimizu T, Yokoyama K, Nakajima H, Kanda Y, Okamoto S. Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors. Int J Hematol.2015;102(3):342-8.
Sumiya C, Arai Y, Takayama M, Abe Y, Hirose N, Asakura K, Nishiwaki Y, Takebayashi T. Vitamin D deficiency and lifestyle factors in the oldest old. Am J Geriatrics Soc.2017;58(11):2242-2244.
Koichi Murakami, Sumiko Kohashi, Masatoshi Sakurai, Jun Kato, Takaaki Toyama, Yuya Koda, Yusuke Yamane, Risa Hashida, Ryohei Abe, Rie Yamazaki, Taku Kikuchi, Takayuki Shimizu, Shigeaki Suzuki, Naoki Hasegawa, Shinichiro Okamoto, Takehiko Mori Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis Int J Hematol.2017;106(3):436-440.
Hidenori Kasahara,Taisuke Kondo, Hiroko Nakatsukasa, Shunsuke Chikuma, Minako Ito, Yutaka Kurebayashi, Takashi Sekiya, Taketo Yamada, Shinichiro Okamoto, Akihiko Yoshimura. Generation of alloantigen-specific induced-Treg stabilized by vitamin C treatment and its application for prevention of acute graft ersus host disease model Int Immunol.2017;29(10):457-469.
Mori T, Kanda Y, Takenaka K, Okamoto S, Kato J, Kanda J, Yoshimoto G, Gondo H, Doi S, Inaba M, Kodera Y. Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial. Int J Hematol.2017;105(2):206-212
Takenaka K, Shimoda K, Uchida N, Shimomura T, Nagafuji K, Kondo T, Shibayama H, Mori T, Usuki K, Azuma T, Tsutsumi Y, Tanaka J, Dairaku H, Matsuo K, Ozawa K, Kurokawa M, Arai S, Akashi K. Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. Int J Hematol.2017;105(1):59-69.
Kobayashi R, Mitsui T, Fujita N, Osumi T, Aoki T, Aoki K, Suzuki R, Fukuda T, Miyamoto T, Kato K, Nakamae H, Goto H, Eto T, Inoue M, Mori T, Terui K, Onizuka M, Koh K, Koga Y, Ichinohe T, Sawada A, Atsuta Y, Suzumiya J. Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation. Int J Hematol.2017;105(3):369-376.
Suzuki K, Sunami K, Ohashi K, Iida S, Mori T, Handa H, Matsue K, Miyoshi M, Bleickardt E, Matsumoto M, Taniwaki M. Randomized phase 3 study of elotuzumab for relapsed or refractory multiple myeloma: ELOQUENT-2 Japanese patient subanalysis. Blood Cancer J.2017;7(3):e540.
Arakaki H, Nakazato T, Osada Y, Ito C, Aisa Y, Mori T. Comparison of R-CVP with R-CHOP for very elderly patients aged 80 or over with diffuse large B cell lymphoma. Ann Hematol.2017;96(7):1225-1226
Horio T, Mizuno S, Uchino K, Mizutani M, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Takami A. The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation. Transpl Immunol.2017;42():34-39.
Uchino K, Mizuno S, Sato-Otsubo A, Nannya Y, Mizutani M, Horio T, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Ogawa S, Takami A. Toll-like receptor genetic variations in bone marrow transplantation. Oncotarget.2017;8(28):45670-45686.
Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Kawakita T, Mori T, Hoshino T, Onizuka M, Ozawa Y, Yoshida S, Ueda Y, Mizuno I, Atsuta Y, Mizuta S; Japan Society for Haematopoietic Cell Transplantation. Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults. Br J Haematol.2017;178(1):106-111.
Saburi M, Kohashi S, Kato J, Koda Y, Sakurai M, Toyama T, Kikuchi T, Karigane D, Yuda S, Yamane Y, Hashida R, Abe R, Nakazato T, Hirahashi J, Ogata M, Okamoto S, Mori T. Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation. Int J Hematol.2017;106(3):431-435.
Murakami K, Kohashi S, Sakurai M, Kato J, Toyama T, Koda Y, Yamane Y, Hashida R, Abe R, Yamazaki R, Kikuchi T, Shimizu T, Suzuki S, Hasegawa N, Okamoto S, Mori T. Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis. Int J Hematol.2017;106(3):436-440.
Kato J, Mori T, Suzuki T, Ito M, Li TC, Sakurai M, Yamane Y, Yamazaki R, Koda Y, Toyama T, Hasegawa N, Okamoto S. Nosocomial BK Polyomavirus infection causing hemorrhagic cystitis among patients with hematological malignancies after hematopoietic stem cell transplantation. Am J Transplant.2017;17(9):2428-2433.
Yamane M, Ogawa Y, Fukui M, Kamoi M, Uchino M, Saijo-Ban Y, Kozuki N, Mukai S, Mori T, Okamoto S, Tsubota K. Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study. Eye Contact Lens.2017 doi: 10.1097/ICL.0000000000000455()
Miyamoto T, Fukuda T, Nakashima M, Henzan T, Kusakabe S, Kobayashi N, Sugita J, Mori T, Kurokawa M, Mori SI. Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program. Biol Blood Marrow Transplant.2017;23(6):938-944.
Ogata M, Oshima K, Ikebe T, Takano K, Kanamori H, Kondo T, Ueda Y, Mori T, Hashimoto H, Ogawa H, Eto T, Ueki T, Miyamoto T, Ichinohe T, Atsuta Y, Fukuda T. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant.2017;52(11):1563-1570.
Onishi Y, Mori T, Kako S, Koh H, Uchida N, Kondo T, Kobayashi T, Yabe H, Miyamoto T, Kato K, Suzuki R, Nakao S, Yamazaki H; Adult Aplastic Anemia Working Group of the Japan Society for Hematopoietic Cell ransplantation. Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Biol Blood Marrow Transplant.2017;23(12):2137-2142.
Namkoong H, Ishii M, Mori T, Sugiura H, Tasaka S, Sakurai M, Koda Y, Kato J, Hasegawa N, Okamoto S, Betsuyaku T. Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation. BMC Pulm Med.2017;17(1):123
Sasaki T, Akiyama M, Kaneko Y, Mori T, Yasuoka H, Suzuki K, Yamaoka K, Okamoto S, Takeuchi T. Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease. RMD Open.2017;18(3):e000432.
Matsushita M, Ozawa K, Suzuki T, Nakamura M, Nakano N, Kanchi S, Ichikawa D, Matsuki E, Sakurai M, Karigane D, Kasahara H, Tsukamoto N, Shimizu T, Mori T, Nakajima H, Okamoto S, Kawakami Y, Hattori Y. Blood Cancer J.2017;7(9):e601.
He J, Ogawa Y, Mukai S, Saijo-Ban Y, Kamoi M, Uchino M, Yamane M, Ozawa N, Fukui M, Mori T, Okamoto S, Tsubota K. In Vivo Confocal Microscopy Evaluation of Ocular Surface with Graft-Versus-Host Disease-Related Dry Eye Disease. Scientific Reports 2017;7(1):10720
Kurosawa S, Oshima K, Yamaguchi T, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant.2017;23(10):1749-1758.
Murata M, Ikegame K, Morishita Y, Ogawa H, Kaida K, Nakamae H, Ikeda T, Nishida T, Inoue M, Eto T, Kubo K, Sakura T, Mori T, Uchida N, Ashida T, Matsuhashi Y, Miyazaki Y, Ichinohe T, Atsuta Y, Teshima T. Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT. Bone Marrow Transplant.2017;52(2):252-257
Konuma T, Miyazaki Y, Uchida N, Ohashi K, Kondo T, Nakamae H, Takahashi S, Mori T, Ozawa Y, Kato C, Iwato K, Fukuda T, Ichinohe T, Atsuta Y, Ishiyama K; Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8. Biol Blood Marrow Transplant.2017;23(1):75-80
Kikuchi T, Mori T, Shimizu T, Koda Y, Abe R, Kurihara Y, Funakoshi T, Yamagami J, Sato H, Tsunoda K, Amagai M, Okamoto S. Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus. Ann Hematol. 2017.;.(96).7
Kikuchi T, Shimizu T, Toyama T, Abe R, Okamoto S. Successful treatment of TAFRO syndrome with tocilizumab, predonisone, and cyclophosphamide. Intern Med 2017.;56.
Hashimoto N, Mori T, Hashida R, Sakurai M, Koda Y, Toyama T, Kato J, Okamoto S. False-positive serum (1, 3)-β-D-glucan elevation due to intake of seaweed in a hematopoietic stem cell transplant recipient. Transplant Infect Dis 2017.;.(19).2
住谷智恵子 PART Ⅵ 血液疾患 / 腫瘍 鑑別診断ネモニクス Mnemonics of Differential Diagnosis for General Internal Medicine 2017年メディカル・サイエンス・インターナショナル
学会発表(国際)
Shinichiro Okamoto Current indication for HCT in adults The 4th WBMT WORKSHP 2017年 Saudi Arabia Oral
Keiichi Tozawa, Yukako Ono-Uruga, Taisuke Mori, Noriko Takizawa, Mitsuru Murata, Shinichiro Okamoto, Yasuo Ikeda, Yumiko Matsubara, Masaki Yazawa Effects of Activated Human Platelet Releasates on Wound Healing of Immunodeficient Mice: Comparison with basic FGF 2017 XXVI ISTH Congress 2017年 Berlin Poster
Shinichiro Okamoto Future Challenges in HSCT- APBMT Perspective The second international congress of organ transplantation 2017年 Mongol Oral
Shinichiro Okamoto Precision medicine in allogenic hematopoietic cell transplantation The International Congress of BMT 2017 2017年 Souel Oral
Shinichiro Okamoto The Japanese perspective: Life after transplantation European Blood and Marrow Transplantation Annual Meetings, 2017年 Marseille Oral
Jun Ho Jang, Shinichiro Okamoto, Masatoshi Sakurai, Wen-Chien Chou, Jin Seok Kim, Amanda Wilson, Jun-ichi Nishimura, Tzeon-Jye Chiou, Jong Wook Lee, Yuzuru Kanakura Comparative study on baseline clinical characteristics of Asian vs. non-Asian patients with paroxysmal nocturnal hemoglobinuria (PNH) Annual Meeting of American Society of Hematology 2017年 Atlanta Poster
Hidenori Kasahara,Shinichiro Okamoto, Takashi Sekiya, Akihiko Yoshimura Vitamin C Stabilizes Foxp3 Expression in Induced Treg Cells By Targeted DNA Demethylation and Prevents Murine Model of Acute Graft Versus Host Disease Annual Meeting of American Society of Hematology 2017年 Atlanta Oral
Ikeda K, Ymada-Fujiwara M, Kanamori H, Fujiwara S, Muroi K, Mori T, Kasama K, Iseki T, Naganuma-Inoue T, Fujii N, Ashida T, Kameda K, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R, Ohto H. Adverse Events Associated with Cryopreserved and Non-Cryopreserved Hematopoietic Stem Cell Infusion: A Prospective and Multicenter Surveillance Study Annual Meeting of American Society of Hematology 2017年 Atlanta Poster
Tokuhira M, Saito S, Okuyama A, Suzuki K, Higashi M, Momose S, Shimizu T, Mori T, Anan-Nemoto T, Amano K, Okamoto S, Takeuchi T, Tamaru J, Kizaki M. Impact of the Duration of Methotrexate Administration and the Specific HLA Alleles on the Regressive Methotrexate-Induced Lymphoproliferative Disorders. Annual Meeting of American Society of Hematology 2017年 Atlanta Poster
Mori T, Onishi Y, Ozawa Y, Kato C, Kimura H, Kanda Y, Kurokawa M, Tanaka M, Ashida T, Taguchi J, Fukuda T, Ichinohe T, Atsuta Y, Yamazaki H. Outcome of allogeneic hematopoietic stem cell transplantation for hepatitis-associated aplastic anemia. ASBMT/IBMTR Tandem BMT Meetings 2017年 Orland Poster
Ryohei Abe, Takehiko Mori, Jun Kato, Masatoshi Sakurai, Shinichiro Okamoto Characteristics of cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation ASBMT/IBMTR Tandem BMT Meetings 2017年 Orlando Poster
Shinichiro Okamoto Current Status and Future Challenges of APBMT Asia Pacific Blood and Marrow Transplantation Group Annual Meeting 2017年 Tehran Oral
Shinichiro Okamoto Precision Medicine in Allogenic Transplantation for Hematologic Malignancies 4th AEGEAN HEMATOLOGY ONCOLOGY SYMPOSIUM AHOS 2017 2017年 Greece Oral
Mori T. Transplant strategy in the treatment of adult acute lymphoblastic leukemia: Japanese experience. Symposium of Korean Society of Hematolog 2017年 Korea Oral
Hidenori Kasahara,Daiki Karigane, Shinichiro Okamoto, Keiyo Takubo Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients Highlights of ASH(American Society of Hematology)in Asia-Pacific 2017年 Hong-Kong Poster
Shinichiro Okamoto Life after transplantation The 4th sourthern vietnam open blood transfusion and hematology conference 2017年 Dalat Oral
Shinichiro Okamoto Current APBMT Activity and HSCT Perspectives in AP region 9th KUDH Cancer Ceter, Biobank, Cancer Institute International Symposium 2017年 Korea Oral
Shinichiro Okamoto Diagnosis and treatment of viral infection following alogenic hematopoietic stem cell transplantation(Allo-HSCT) BEST of EBMT 2017 China 2017年 China Oral
Fujita H, Sasaki T, Miyamoto T, Mori T, Nakabayashi K, Hata K, Matsuura S, Matsubara Y, Amagai M, Kubo A. Genetic characterization of a patient with a progeroid phenotype and mosaic variegated aneuploidy Keystone Symposia: Aging and Mechanism of Aging-related disesease, 2017年 Yokohama oral/poster
戸澤圭一、小野-宇留賀友佳子、矢澤真樹、森泰昌、村田満、岡本真一郎、池田康夫、松原由美子 Function of Manufactured Platelets from Adipose Stem Cell Line: Compared to Platelet Concentrates 第79回日本血液学会学術集会 2017年 東京 口演
Ikeda T, Mori K, Kawamura K, Mori T, Hagiwara S, Ueda Y, Kahata K, Uchida N,Tsukada N, Murakami S, Yamamoto M, Takahashi T, Ichinohe T, Onizuka M, Atsuta Y, Kanda Y, Okamoto S, Sunami K. Allogenic SCT for multiple myeloma relapsing or progressing after prior autologous SCT: JSHCT MM-WG. 第79回日本血液学会総会 2017年 横浜 口演
Mori T, Kato J, Suzuki T, Ito M, Tian C, Okamoto S. Nosocomial BK polyomavirus infection among patients with hematological disorders. 第79回日本血液学会総会 2017年 横浜 優秀ポスター
Mori T, Suzumiya J, Kurokawa M, Kahata K, Fukuda T, Hirokawa M, Atsuta Y. Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides/Sezary syndrome. 第79回日本血液学会総会 2017年 横浜 ポスター
Ogata M, Takano K, Moriuchi Y, Kondo T, Ueki T, Nakano N, Mori T, Uoshima N, Jo Y, Sakai R, Yamasaki S, Choi I, Kato K, Shibasaki Y, Fukuda T. Foscarnet for the prevention of HHV-6 encephalitis in cord blood transplantation. 第79回日本血液学会総会 2017年 横浜 口演
Chin DW, Sakurai M, Nah GS, Du L, Jacob B, Yokomizo T, Matsumura T, Suda T, Huang G, Fu XY, Ito Y, Nakajima H, Osato M. RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity. Blood Cancer J. 2016;86:e379.
Sakurai M, Kasahara H, Yoshida K, Yoshimi A, Kunimoto H, Watanabe N, Shiraishi Y, Chiba K, Tanaka H, Harada Y, Harada H, Kawakita T, Kurokawa M, Miyano S, Takahashi S, Ogawa S, Okamoto S, Nakajima H. Genetic basis of myeloid transformation in familial platelet disorder/acute myeloid leukemia patients with haploinsufficient RUNX1allele Blood Cancer J. 2016;56:e392.
Karigane D, Kobayashi H, Morikawa T, Ootomo Y, Sakai M, Nagamatsu G, Kubota Y, Goda N, Matsumoto M, Nishimura EK, Soga T, Otsu K, Suematsu M, Okamoto S, Suda T, Takubo K. p38α Activates Purine Metabolism to Initiate Hematopoietic Stem/Progenitor Cell Cycling in Response to Stress. Cell Stem Cell. 2016;192:192-204.
Yakushijin K, Atsuta Y, Doki N, Yokota A, Kanamori H, Miyamoto T, Ohwada C, Miyamura K, Nawa Y, Kurokawa M, Mizuno I, Mori T, Onizuka M, Taguchi J, Ichinohe T, Yabe H, Morishima Y, Kato K, Suzuki R, Fukuda T. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes. Bone Marrow Transplant. 2016;513:403-9.
Itonaga H, Iwanaga M, Aoki K, Aoki J, Ishiyama K, Ishikawa T, Sakura T, Fukuda T, Najima Y, Yujiri T, Mori T, Kurokawa M, Nawa Y, Uchida N, Morishita Y, Hashimoto H, Eto T, Hirokawa M, Morishima Y, Nagamura-Inoue T, Atsuta Y, Miyazaki Y. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study. Leuk Res. 2016;41:48-55.
Kanda Y, Kobayashi T, Mori T, Tanaka M, Nakaseko C, Yokota A, Watanabe R, Kako S, Kakihana K, Kato J, Tanihara A, Doki N, Ashizawa M, Kimura SI, Kikuchi M, Kanamori H, Okamoto S. A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation. Bone Marrow Transplant. 2016;511:103-9.
Mori T, Kato J, Sakurai M, Hashimoto N, Kohashi S, Hashida R, Saburi M, Kikuchi T, Yamane Y, Hoshino K, Okamoto S. New-onset food allergy following cord blood transplantation in adult patients. Bone Marrow Transplant. 2016;512:259-6.
Mori T, Koh H, Onishi Y, Kako S, Onizuka M, Kanamori H, Ozawa Y, Kato C, Iida H, Suzuki R, Ichinohe T, Kanda Y, Maeda T, Nakao S, Yamazaki H. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling. Int J Hematol. 2016;1034:461-8
Yanada M, Yano S, Kanamori H, Gotoh M, Emi N, Watakabe K, Kurokawa M, Nishikawa A, Mori T, Tomita N, Murata M, Hashimoto H, Henzan H, Kanda Y, Sawa M, Kohno A, Atsuta Y, Ichinohe T, Takami A. Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide. Leuk Lymphoma. 2016;585:1061-1067.
Kuwatsuka Y, Kanda J, Yamazaki H, Mori T, Miyamura K, Kako S, Uchida N, Ohashi K, Ozawa Y, Takahashi Y, Kato C, Iwato K, Ishiyama K, Kobayashi H, Eto T, Kahata K, Kato J, Miyamoto T, Kato K, Mori S, Atsuta Y, Kimura F, Kanda Y; Japan Society for Hematopoietic Cell Transplantation. A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia. Biol Blood Marrow Transplant. 2016;2210:1836-43.
Uchino K, Mizuno S, Mizutani M, Horio T, Hanamura I, Espinoza JL, Matsuo K, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Takami A; Japan Marrow Donor Program. Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies. Transpl Immunol. 2016;38:22068
Atsuta Y, Hirakawa A, Nakasone H, Kurosawa S, Oshima K, Sakai R, Ohashi K, Takahashi S, Mori T, Ozawa Y, Fukuda T, Kanamori H, Morishima Y, Kato K, Yabe H, Sakamaki H, Taniguchi S, Yamashita T; Late Effect and Quality of Life Working Group of the Japan Society for Hematopoietic Cell Transplantation. Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016;229:1702-9.
Ishiyama K, Yamaguchi T, Eto T, Ohashi K, Uchida N, Kanamori H, Fukuda T, Miyamura K, Inoue Y, Taguchi J, Mori T, Iwato K, Morishima Y, Nagamura-Inoue T, Atsuta Y, Sakamaki H, Takami A. Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCT. Leuk Res. 2016;47:47-53.
Kawamura K, Ikeda T, Hagiwara S, Mori T, Shinagawa A, Nishiwaki K, Ohashi K, Kubonishi S, Fukuda T, Ito T, Tomita N, Ichinohe T, Kato K, Morishima Y, Atsuta Y, Sunami K, Kanda Y. Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis. Leuk Lymphoma. 2016;579:2077-83
Arai Y, Kondo T, Yamazaki H, Takenaka K, Sugita J, Kobayashi T, Ozawa Y, Uchida N, Iwato K, Kobayashi N, Takahashi Y, Ishiyama K, Fukuda T, Ichinohe T, Atsuta Y, Mori T, Teshima T; Japan Society for Hematopoietic Cell Transplantation. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia. Haematologica. 2016;1015:664-52.
Sakai R, Taguri M, Oshima K, Mori T, Ago H, Adachi S, Morita S, Taniguchi S, Fukuda T, Ohashi K, Eto T, Miyamura K, Iwato K, Kobayashi N, Kanamori H, Morishima Y, Nagamura-Inoue T, Sakamaki H, Atsuta Y, Murata M. A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey. Int J Hematol. 2016;1033:322-33.
Asakura T, Ishii M, Kikuchi T, Kameyama K, Namkoong H, Nakata N, Sugita K, Tasaka S, Shimizu T, Hoshino Y, Okamoto S, Betsuyaku T, Hasegawa N. Disseminated Mycobacterium marinum Infection With a Destructive Nasal Lesion Mimicking Extranodal NK/T Cell Lymphoma;A Case Report. Medicine (Baltimore). 2016;95(11).e3131
Mori T, Kato J, Sakurai M, Hashimoto N, Kohashi S, Hashida R, Saburi M, Kikuchi T, Yamane Y, Hoshino K, Okamoto S New-onset food allergy following cord blood transplantation in adult patients. Bone Marrow Transplant 2016;51(2).295-296
Masatoshi Sakurai, Takehiko Mori, Daiki Karigane, Hidenori Kasahara, Keiichi Tozawa, Eri Matsuki, Taku Kikuchi, Jun Kato, Takayuki Shimizu, Shinichiro Okamoto Long-Term Treatment with Imatinib Is Associated with Decreased Estimated Glomerular Filtration Rate and Hemoglobin Level in Patients with Chronic Myelogenous Leukemia. Annual Meeting of American Society of Hematology 2016年 San Diego Poster
Karigane D, Kasahara H, Sakurai M, Matsuki E, Tozawa K, Koda Y, Totama T, Kikuchi T, Kato J, Shimizu T, Mori T, Yahagi K, Yatabe Y, Arai T, Katagiri N, Shimizu N, Mitsuhashi Y, Murata M, Kobayashi H, Takubo K, Okamoto S Correlation of Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients. Annual Meeting of American Society of Hematology 2016年 San Diego Poster
Keiichi Tozawa, Yukako Ono-Uruga, Masaki Yazawa, Taisuke Mori, Noriko Takizawa, Mitsuru Murata, Shinichiro Okamoto, Yasuo Ikeda, Yumiko Matsubara Manufacture of Platelets from Human Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells: Functional Comparison to Concentrate Platelets. Annual Meeting of American Society of Hematology 2016年 San Diego Oral
Tokuhira M, Saito S, Tanaka Y, Takahashi Y, Kimura Y, Tomikawa T, Anan T, Momose S, Higashi M, Shimizu T, Mori T, Tabayashi T, Watanabe R, Tamaru J, Okamoto S, Kizaki M. CD14-CD15+, Possible Cells Are Potent Myeloid-Derived Suppressor Cells, Which Affect the Pathogenesis of Induction and Regression in Methotrexate-Mediated Lymphoproliferative Disorders. Annual Meeting of American Society of Hematology 2016年 San Diego Poster
Takenaka K, Shimoda K, Uchida N, Shimomura T, Nagafuji K, Kondo T, Shibayama H, Mori T, Usuki K, Azuma T, Tsutsumi Y, Tanaka J, Dairaku H, Matsuo K, Ozawa K, Kurokawa M, Arai S, Akashi K. Clinical Outcomes of Patients with Primary Myelofibrosis in Japan: A Nationwide Survey over a 17-Year Study Period. Annual Meeting of American Society of Hematology 2016年 San Diego Poster
Kurosawa S, Oshima K, Yamaguchi T, Yanagisawa A, Fukuda T, Kanamori H, Mori T, TakahashiS, KondoT, Kohno A, Seto A, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Atsuta Y. Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd. Annual Meeting of American Society of Hematology 2016年 San Diego Poster
Matsuki E, Sakurai M, karigane D, kasahara H, Kikuchi T, Shimizu T, Yokoyama K, Mori T, Okamoto S. Second Attempt to Discontinue TKI in CML Patients Who Have Sustained CMR for over 2 Years Is Rarely Successful Even with the Use of Second Generation TKIs. Annual Meeting of American Society of Hematology 2016年 San Diego Poster
Karigane D, Hidenori Kasahara, Sakurai M, Matsuki E, Tozawa K, Koda Y, Toyama T, Kikuchi T, Kato J, Shimizu T, Mori T, Yatabe T, Arai T, Mitshuhashi T, Murata M, Koyahashi H, Takuo K, Okamoto S. Correlation of Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients. Annual Meeting of American Society of Hematology 2016年 San Diego Poster
Shinichiro Okamoto Design the Future of Hematopietic Stem Cell Transplantation: APBMT Perspective. Asia Pacific Blood and Marrow Transplantation Group Annual Meeting, 2016年 Singapore Oral
Shinichiro Okamoto Acute GVHD: Progress in the Management of Acute GvHD - Japanese Experience. Asia Pacific Blood and Marrow Transplantation Group Annual Meeting, 2016年 Singapore Oral
Yamane Y, Kato J, Mori T, Hashida R, Koda Y, Sakurai M, Toyama T, Kohashi S, Kikuchi T, Okamoto S. Retrospective evaluation of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Asia Pacific Blood and Marrow Transplantation Group Annual Meeting, 2016年 Singapore Poster
Koh M, Mori T, Kato J, K, Sakurai M, Kikumi O, OkamotoS. Clinical features and outcome of cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation. Asia Pacific Blood and Marrow Transplantation Group Annual Meeting, 2016年 Singapore Poster
Mori T, Kato J, K, Sakurai M, Kikumi O, Okamoto S. Seasonal variations in the number and species of indoor airborne fungi in hematopoietic stem cell transplantation/hematology ward. Asia Pacific Blood and Marrow Transplantation Group Annual Meeting, 2016年 Singapore Poster
Kato J, Kasahara H, Matsuki E, Kikuchi T, Kohashi S, Koda Y, Sakurai M, Toyama T, OkamotoS, Mori T. A phase 1 study of high-dose melphalan in comibination with bortezomib as conditioning of autologous stem cell transplantation (ASCT) for multiple myeloma. Asia Pacific Blood and Marrow Transplantation Group Annual Meeting, 2016年 Singapore Poster
Shinichiro Okamoto Recent advances in the management of graft-versus-host disease (GVHD). Fousing on acute GVHD. 4th VIETNAMESE-FRENCH OPEN BLOOD AND MARROW TRANSPLANTATION CONGRESS 2016年 Nha Trang City Oral
Mori A, Tsukagoshi M, Kurosawa S, Mori T, Kanamori H, Onishi Y, Emi N, Fujisawa S, Kohno A, Nakaseko C, Saito B, Kondo T, Hino M, Nawa Y, Kato S, Hashimoto A, Inamoto Y, Fukuda T. Qualitative Analysis of Patient-Reported Free Comments on Quality of Life in Patients Who Completed Treatment for Acute Leukemia. ASBMT/IBMTR Tandem BMT Meetings 2016年 Honolulu Poster
Kohashi S, Mori T, Kato J, Kobayashi H, Okamoto S. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for follicular lymphoma and clinical evidence of graft-versus-lymphoma effect in post-transplant relapsed patients. ASBMT/IBMTR Tandem BMT Meetings 2016年 Honolulu Poster
Mori T, Ohashi K, Kanamori H, Sakura T, Yano S, Kanda Y, Kako S, Tachibana T, Yokota A, Onizuka M, Nakaseko C, Okamoto S. Comparison between busulfan with cyclophosphamide and busulfan with fludarabine as myeloablative conditioning of allogeneic hematopoietic stem cell transplantation for myeloid malignancies. ASBMT/IBMTR Tandem BMT Meetings 2016年 Honolulu Poster
学会発表(国内)
櫻井政寿、森毅彦、雁金大樹、笠原秀範、戸澤圭一、松木絵里、菊池拓、加藤淳、清水隆之、岡本真一郎 Association between renal dysfunction and hemoglobin levels under long-term imatinib treatment 第78回日本血液学会学術集会 2016年
城下郊平、坂本光男、外山高朗、横山裕章、細田智弘、岡野裕、野崎博之 Corynebacterium striatum bacteremia complicated with aplastic anemia 第78回日本血液学会学術集会 2016年
Mori T, Kanda Y, Takenaka K, Okamoto S, Gondo H, Doi S, Inaba M, Kodera Y n open Label phase 2 trial to evaluate the safety of a cytomegalovirus (CMV) vaccine, ASP0113, for CMV infection in recipients undergoing allogeneic hematopoietic cell transplant 第38回日本造血細胞移植学会総会 2016年
Sakurai M, Mori T, Karigane D, Tozawa K, Matsuki E, Shimizu T, Yokoyama K, Nakajima H, Kanda Y, Okamoto S. Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors. Int J Hematol.2015;1023:342-8.
Kikuchi T, Mori T, Koda Y, Kohashi S, Kato J, Toyama T, Nakazato T, Aisa Y, Shimizu T, Okamoto S. Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma Int J Hematol2015;10251:670-677.
Nakayama H, Aisa Y, Ito C, Shimazaki K, Katsumata Y, Hayashi H, Nakazato T. Importance of Histologic Verification of Positive Positron Emission Tomography/Computed Tomography Findings in the Follow-Up of Patients With Malignant Lymphoma. Clinical Lymphoma & Myeloma & Leukemia.2015;1512:753–760.
Kohashi S, Mori T, Hashida R, Kato J, Saburi M, Kikuchi T, Koda Y, Toyama T, Yamane Y, Yamanaka S, Okamoto S. Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogenic hematopoietic stem cell transplantation for aplastic anemia. Int J Hematol.2015;1011:102-5.
Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M. Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation. Bone Marrow Transplant.2015;504:559-65.
Morishima Y, Kashiwase K, Matsuo K, Azuma F, Morishima S, Onizuka M, Yabe T, Murata M, Doki N, Eto T, Mori T, Miyamura K, Sao H, Ichinohe T, Saji H, Kato S, Atsuta Y, Kawa K, Kodera Y, Sasazuki T; Japan Marrow Donor Program. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation. Blood.2015;1257:1189-97.
Fuji S, Mori T, Khattry N, Cheng J, Do YR, Yakushijin K, Kohashi S, Fukuda T, Kim SW. Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality. Bone Marrow Transplant. 2015;501:100-5.
Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T. Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation: the Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Biol Blood Marrow Transplant.2015;2110:2008-2016.
Motohashi K, Fujisawa S, Onizuka M, Kako S, Sakaida E, Shono K, Tatara R, Doki N, Mori T, Sakura T, Aotsuka N, Fuji E, Tomita N, Kawai N, Saitoh T, Usuki K, Taguchi J, Watanabe R, Kobayashi S, Yano S, Kanamori H, Takahashi S, Okamoto S. Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant.2015;5011:1476-9.
Yano S, Mori T, Kanda Y, Kato J, Nakaseko C, Fujisawa S, Tomita N, Sakai R, Shono K, Saitoh T, Aotsuka N, Kobayashi N, Saito T, Takahashi S, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma. Bone Marrow Transplant.2015;5010:1299-305.
Kurosawa S, Yamaguchi T, Mori T, Kanamori H, Onishi Y, Emi N, Fujisawa S, Kohno A, Nakaseko C, Saito B, Kondo T, Hino M, Nawa Y, Kato S, Hashimoto A, Fukuda T. Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia. Bone Marrow Transplant.2015;509:1241-9.
Konuma T, Takahashi S, Uchida N, Kuwatsuka Y, Yamasaki S, Aoki J, Onishi Y, Aotsuka N, Ohashi K, Mori T, Masuko M, Nakamae H, Miyamura K, Kato K, Atsuta Y, Kato S, Asano S, Takami A, Miyazaki Y; Adult Myelodysplastic Syndrome and Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in Japan. Biol Blood Marrow Transplant.2015;219:1632-40.
Kanda J, Ichinohe T, Fuji S, Maeda Y, Ohashi K, Fukuda T, Miyamura K, Iwato K, Eto T, Nakamae H, Kobayashi N, Mori T, Mori S, Morishima Y, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant.2015;212:305-11.
Nomoto H, Takami A, Espinoza JL, Matsuo K, Mizuno S, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Ohtake S, Morishita E. A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation. Int J Hematol.2015;1024:460-70.
Mashima K, Suzuki S, Mori T, Shimizu T, Yamada S, Hirose S, Okamoto S, Suzuki N. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin's lymphoma. Int J Hematol.2015;1026:709-12.
Arima N, Nakamura F, Yabe T, Tanaka J, Fuji S, Ohashi K, Fukuda T, Miyamura K, Iwato K, Eto T,Mori T, Kobayashi N, Hoshino T, Kato C, Kanamori H, Nakamae H, Atsuta Y, Morishima Y, Kanda Y. Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia: A Japanese National Registry Study. Biol Blood Marrow Transplant.2015;223:423-31.
Mishima K, Obara H, Sugita K, Shinoda M, Kitago M, Abe Y, Hibi T, Yagi H, Matsubara K, Mori T, Takano Y, Fujiwara H, Itano O, Hasegawa N,Iwata S, Kitagawa Y Helicobacter cinaedi bacteremia with cellulitis after ABO-incompatible living-donor liver transplantation: Case report. World J Gastroenterol. 2015;21(7911-7915).7911-7915
Mashima K, Suzuki S, Mori T, Shimizu T, Yamada S, Hirose S, Okamoto S, Suzuki N. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin's lymphoma. Int J Hematol 2015;102.709-712
Kasahara H, Mori T, Kato J, Koda Y, Kohashi S, Kikuchi T, Sakurai M, Yamane Y, Mikami S, Kameyama K, Takahashi Y, Okamoto S. Post-transplant lymphoproliferative disorder of the adrenal gland after allogeneic hematopoietic stem cell transplantation: report of two cases and literature review. Transpl Infect Dis 2015;17.909-914
Taku Kikuchi, Takehiko Mori, Yuya Koda, Masuho Saburi, Sumiko Kohashi, Takaaki Toyama, Jun Kato, Subaru Hashimoto, Masayuki Nakatsuka, Hirotoshi Ebinuma, Shinichiro Okamato. Evaluation of safety and utility of transjugular liver biopsy in allogeneic hematopoietic stem cell transplant recipients. 2015 KSBMT 2015年 Pyeongchang Poster
Keiichi Tozawa, Yukako Ono-Uruga, Tadashi Horiuchi, Shinichiro Okamoto, Mitsuru Murata, Yasuo Ikeda, Toshio Suda, Yumiko Matsubara Identification of Megakaryocytic Progenitor Cells among Subcutaneous Pre-adipocytes Thrombopoietin 2015 XXV ISTH Congress 2015年 Toronto Poster
Karigane D, Shinichiro O, Suda T, Takubo K p38α activates purine metabolism to initiate hematopoietic stem cell cycling Annual Meeting of American Society of Hematology 2015年 Orlando Oral
Keiichi Tozawa, Yukako Ono-Uruga, Noriko Takizawa, Tadashi Horiuchi, Shinichiro Okamoto, Mitsuru Murata, Yasuo Ikeda, Yumiko Matsubara Establishment of Human Adipose Tissue-derived Stromal Cell Lines: a Culture System to Manufacture Megakaryocytes Releasing Functional Platelets Annual Meeting of American Society of Hematology 2015年 Orlando Oral
Risa Hashida, Takehiko Mori,Jun Kato,Sumiko Kohashi, Shinichiro Okamoto Effect of Linezolid Administration on Myeloid Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation ASBMT/IBMTR Tandem BMT Meetings 2015年 San Diego Poster
Ryohei Abe, Takehiko Mori, Norisato Hashimoto, Sumiko Kohashi, Jun Kato, Naoki Hasegawa and Shinichiro Okamoto Preexisting tuberculous lymphadenitis detected by positron emission tomography in a patient with adult T-cell leukemia/lymphoma progressing to disseminated disease after cord blood transplantation Asia Pacific Blood and Marrow Transplantation Group Annual Meeting, 2015年 Okinawa Poster
Shinichiro Okamoto Infectious Complication after Hematopoietic Stem Cell Transplantation Asia Pacific Blood and Marrow Transplantation Group Annual Meeting, 2015年 Indonesia Oral
Shinichiro Okamoto Single-Unit Cord Blood Transplantation with Myeloablatve Conditioning for Adult Patients with High-Risk Hematological Malignancies Asia Pacific Blood and Marrow Transplantation Group Annual Meeting, 2015年 Indonesia Oral
Shinichiro Okamoto Multidisciplinary team approach for allogenic hematopoietic stem cell transplantation(HSCT) 5th conference of myanmar society of haematology 2015年 Myanmar Oral
Karigane D, Suda T, Takubo K Proliferation of transplanted hematopoietic stem cells in controlled by p38α-activated purine metabolism Stem Cell Research Symposium 2015年 Tokyo Oral
Kohashi S, Mori T, Hashida R, Toyama T, Kohashi S, Kato J, Okamoto S. Allogeneic hematopoietic stem cell transplantations for trisomy 8-positive myeloid malignancies complicated with Behçet's disease-like colitis. Asia Pacific Blood and Marrow Transplantation Group Annual Meeting 2015年 Okinawa Poster
Toyama T, Mori T, Koda Y, Kohashi S, Kikuchi T, Kato J, Okamoto S. Allogeneic hematopoietic stem cell transplantation for older patients with myeloid malignancy with a myeloablative conditioning consisting of TBI and G-CSF-combined cytarabine: a comparison with younger patients Asia Pacific Blood and Marrow Transplantation Group Annual Meeting 2015年 Okinawa Poster
Abe, R, Mori T, Hashimoto N, Kohashi S, Kato J, Hasegawa N, Okamoto S. Preexisting tuberculous lymphadenitis detected by positron emission tomography in adult T-cell leukemia/lymphoma progressing to disseminated disease after cord blood transplantation. Asia Pacific Blood and Marrow Transplantation Group Annual Meeting 2015年 Okinawa Poster
Mori T, Sakurai M, Jun Kato, Okamoto S. Sinusitis due to Exserohilum rostratum after cord blood transplantation for myelodysplastic syndrome: a case report and literature review. Asia Pacific Blood and Marrow Transplantation Group Annual Meeting 2015年 Okinawa Poster
Mori T. Invasive fungal disease in high-risk patients-How to assess the risk? 2nd Asia Care Forum 2015年 Taipei Oral Lecutre
Mori T. Managing invasive fungal infection in Haemato-Oncology patients. Infectious Disease Education and Learning Summit 2015年 Incheon Oral Lecutre
Kikuchi T, Mori T, Koda Y, Saburi M, Kohashi S, Toyama T, Kato J, Hashimoto S, Nakatsuka M, Ebinuma H, Okamoto S. Evaluation of safety and utility of transjugular liver biopsy in allogeneic hematopoietic stem cell transplant recipients. 19th Annual Winter Meeting of Korean Society of Hematology 2015年 Pyeongchang Poster
Mori T, Kato J, Kohashi S, Okamoto S. Transplant-acquired food allergy following cord blood transplantation in adult patients. ASBMT/IBMTR Tandem BMT Meetings 2015年 San Diego Poster
戸澤圭一、小野-宇留賀友佳子、瀧澤典子、堀内正、池田康夫、岡本真一郎、松原由美子 Establishment and Characterization of Human Pre-adiposyte Cell Line for Manufacturing Platelets 第77回日本血液学会学術集会 2015年 金沢 口演
Ogura H, Aoki T, Utugizsawa T, Mori T, Kanno H Significance of gene analysis in a patient with hemolytic anemia in the adulthood 第77回日本血液学会総会 2015年 金沢 ポスター
Kuwatsuka Y, Yamazaki H, Kanda J, Kimura F, Kako S, Mori T, Uchida N, Ohashi K, Ozawa Y, Takahashi Y, Kato C, Iwato K, Kato K, Mori S, Atsuta Y, Miyamura K, Kanda Y. Cord blood and unrelated bone marrow transplant outcomes for adult aplastic anemia: JSHCT WG study 第77回日本血液学会総会 2015年 金沢 口演
Nishida T, Onishi Y, Kobayashi T, Mori T, Shirafuji N, Kanamori H, Miyazaki Y, Ichinohe T, Atsuta Y, Murata M. Graft-versus-host disease after syngeneic hematopoietic stem cell transplantation. 第77回日本血液学会総会 2015年 金沢 口演
Kanda Y, Kobayashi T, Mori T, Tanaka M, Nakaseko C, Yokota A, Watanabe R, Kako S, Kakihana K, Kato J, Tanihara A, Doki N, Ashizawa M, Kimura S, Kikuchi M, Kanamori H, Okamoto S. Randomized comparison of cyclosporine at 500 ng/mL and tacrolimus at 15 ng/mL after unrelated SCT. 第77回日本血液学会総会 2015年 金沢 口演
Kawamura K, Ikeda T, Hagiwara S, Mori T, Shinagawa A, Nishiwaki K, Ohashi K, Kubonishi S, Ichinohe T, Kato K, Morishima Y, Atsuta Y, Sunami K, Kanda Y. Tandem autologous vs. autologous/allogeneic transplantation for myeloma・Propensity score analysis. 第77回日本血液学会総会 2015年 金沢 口演
Shimizu H, Saitoh T, Sakura T, Kawai N, Owada C, Yokota A, Watanabe R, Aotsuka N, Nannya Y, Doki N, Kobayashi S, Yano S, Mori T, Goto M, Usuki K, Tsukada N, Tachibana T, Tanaka M, Fujisawa S, Machida S, Ohashi K, Nakaseko C, Kanda Y, Kanamori H, Takahashi S, Okamoto S. Prognostic impact of cytogenetic abnormalities in adults with Ph-negative ALL who underwent SCT. 第77回日本血液学会総会 2015年 金沢 口演